The Latest

  • A scale is foregrounded against the sky.
    Image attribution tooltip
    zennie via Getty Images

    How do Biogen-Eisai’s two Alzheimer’s drugs stack up?

    Biogen and Eisai's newest Alzheimer's success begs comparison to their past debacle — and bolsters the amyloid theory.

  • magic mushroom
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    Compass has the most advanced psychedelic drug in trials — but it needs a new approach to rollout to make it a success

    The company's CEO, Kabir Nath, discusses potential roadblocks to commecialization that await its psilocybin treatment for depression. 

  • Samantha Dale Strasser headshot
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Pepper Bio’s Samantha Dale Strasser

    The co-founder of Pepper Bio entered the biotech world three years ago with the goal of transforming drug discovery through the emerging discipline of transomics.

  • Autism stock
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    Why precision medicine could be the next frontier in treating autism

    Swiss-based Stalicla is banking on an AI-driven precision medicine discovery platform to deliver needed therapies in the autism space.

  • Mobile phone medical doctor
    Image attribution tooltip
    NanoStockk via Getty Images
    Q&A

    That’s not Angry Birds — that’s your doctor learning about novel drugs through gaming

    How pharma companies can teach physicians about mechanism of action and other medication lessons with interactive mobile games.

  • An illustration of stacked glowing silhouettes.
    Image attribution tooltip

    Illustration: Matthieu Bourel for Industry Dive

    PharmaVoice 100

    The 2022 PharmaVoice 100

    From standout executives to R&D pioneers — this year’s class of honorees is defining the next era of leadership.

  • Header image for Red Jacket Awards
    Image attribution tooltip
    Shaun Lucas/PharmaVoice

    The 2022 Red Jacket honorees

    Our annual PharmaVoice 100 “hall of fame” winners raise the bar on transformative leadership in life sciences.

  • A portrait of Ben Yerxa framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Ben Yerxa
    Profile // PharmaVoice 100

    Entrepreneurs: Ben Yerxa

    The CEO in retinal diseases sees opportunities for drug development success by merging the work of a gene therapy startup with venture philanthropy.

  • A portrait of John Oyler framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by John Oyler
    Profile // PharmaVoice 100

    Entrepreneurs: John Oyler

    The CEO of BeiGene is using innovative business strategies to help the oncology biotech quickly hit new heights.

  • A portrait of Dr. Penelope Manasco framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Penelope Manasco
    Profile // PharmaVoice 100

    Entrepreneurs: Dr. Penelope Manasco

    How the NIH-trained scientist and CEO of MANA RBM is charting a new way forward in conducting clinical trials.

  • A portrait of Bobak Azamian framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Bobak Azamian
    Profile // PharmaVoice 100

    Entrepreneurs: Dr. Bobak Azamian

    The CEO is bringing his vision for innovative eye therapies to Tarsus Pharmaceuticals.

  • A portrait of WeiQing Zhou framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by WeiQing Zhou
    Profile // PharmaVoice 100

    Entrepreneurs: WeiQing Zhou

    The COO has launched two jewels in the biotech world that complement each other while serving broader innovation goals throughout the industry. 

  • A portrait of Jeanne Magram framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jeanne Magram
    Profile // PharmaVoice 100

    Innovators: Jeanne Magram

    Celsius Therapeutics’ CSO is turning ideas into approved medicines for patients with cancer and autoimmune diseases.

  • A portrait of Andrew Miller framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Andrew Miller
    Profile // PharmaVoice 100

    Entrepreneurs: Andrew Miller

    The founder and COO of Karuna Therapeutics is leveraging a combination of persistence and adaptability to scale up the biopharmaceutical company.

  • A portrait of Dr. Cristian Massacesi framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Cristian Massacesi
    Profile // PharmaVoice 100

    Innovators: Dr. Cristian Massacesi

    With the goal of redefining how medicines are made, the CMO and oncology CDO is transforming AstraZeneca’s oncology development.

  • A portrait of Jim Doherty framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jim Doherty
    Profile // PharmaVoice 100

    Innovators: Jim Doherty

    Sage Therapeutics’ chief development officer is leveraging innovative development strategies to create success against hard-to-treat brain disorders.

  • A portrait of Dr. Judith Klimovsky framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Judith Klimovsky
    Profile // PharmaVoice 100

    Innovators: Dr. Judith Klimovsky

    The executive vice president and chief business officer of Genmab is using decades of experience in oncology R&D to fuel advances in antibody-drug conjugates. 

  • A portrait of Barbara Klencke framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Barbara Klencke
    Profile // PharmaVoice 100

    Innovators: Dr. Barbara Klencke

    The chief medical officer at Sierra Oncology, a GSK company, is working to make high-impact changes for rare cancer patients.

  • A portrait of Jennifer Kelly framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jennifer Kelly
    Profile // PharmaVoice 100

    Tech Wizards: Jennifer Kelly

    The president of patient experience is helping transform clinical trials with an innovative platform.

  • A portrait of Kunal Ghosh framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kunal Ghosh
    Profile // PharmaVoice 100

    Tech Wizards: Kunal Ghosh

    The leader of Inscopix embodies a 'bootstrap' approach to entrepreneurship, from soldering early versions of the Inscopix technology to taking a 'science-first' approach to fundraising.

  • A portrait of Houda Hachad framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Houda Hachad
    Profile // PharmaVoice 100

    Tech Wizards: Houda Hachad

    This inventor and 'entrepreneurial scientist' is developing new technologies to manage data and use insights from genomic testing at AccessDx Laboratory.

  • A portrait of Baba Shetty framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Baba Shetty
    Profile // PharmaVoice 100

    Tech Wizards: Baba Shetty

    The pragmatic president of technology and data solutions at Syneos Health helps healthcare companies do what they imagine.

  • A portrait of Nekzad Shroff framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nekzad Shroff
    Profile // PharmaVoice 100

    Tech Wizards: Nekzad Shroff

    Considered one of the industry’s ‘most powerful minds,’ the VP of product management at Saama is developing digital solutions with impact.

  • A portrait of Laurent Levy framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Laurent Levy
    Profile // PharmaVoice 100

    Disrupters: Laurent Levy

    Nanobiotix’s co-founder is applying the principles of nanophysics to fight cancer with a universal mechanism of action.

  • A portrait of Dr. Yvonne Greenstreet framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Yvonne Greenstreet
    Profile // PharmaVoice 100

    Disrupters: Dr. Yvonne Greenstreet

    The CEO of Alnylam — a leader in RNAi therapies — has the company at the top of its game scientifically and culturally.